LX4211
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for LX4211, covering 2011-03-03 to 2015-10-02. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study Between 400 mg LX4211 Tablets and 2 X 200 mg LX4211 Tablets [Phase 1]